SCHEMBL12293447

SCHEMBL12293447

CC(C)c1ccc(S(=O)(=O)N2CCN(C(=O)N(C)C)CC2C(=O)NCc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 4/20 0.45
FKBP1A P62942 1/20 0.44
RAB9A P51151 1/20 0.44
MMP1 P03956 6/20 0.44
MMP3 P08254 6/20 0.44
MMP7 P09237 5/20 0.44
MMP9 P14780 5/20 0.44
MMP13 P45452 5/20 0.44
GAA P10253 1/20 0.43
CCR4 P51679 1/20 0.42
P2RX7 Q99572 1/20 0.42
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2441912 0.91 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2441463 0.91 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2440433 0.91 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL4582127 0.91 FKBP1A (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2438909 0.91 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL4460544 0.90 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2443915 0.90 TRPA1 (0.45) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2442351 0.90 MMP1 (0.48) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL12293803 0.90 TRPA1 (0.45) TRPA1FKBP1AMMP1MMP3MMP7
SCHEMBL2438744 0.90 FKBP1A (0.47) TRPA1FKBP1AMMP1MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017612-B2 therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors JAPAN TOBACCO INC. (JP) 2011-09-13 US disclosed
US-8017612-B2 therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors JAPAN TOBACCO INC. (JP) 2011-09-13 US disclosed
EP-2009004-A1 NOVEL PIPERAZINE COMPOUND, AND USE THEREOF AS HCV POLYMERASE INHIBITOR Japan Tobacco, Inc. (JP) 2008-12-31 EP disclosed